A network meta‐analysis of CYP2C9 , CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype‐based warfarin dosing strategies compared to traditional-Reference-Cited by-同舟云学术

A network meta‐analysis of CYP2C9 , CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype‐based warfarin dosing strategies compared to traditional

Published:2020-12-21 Issue:3 Volume:46 Page:640-648
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Sridharan Kannan¹^ORCID,Sivaramakrishnan Gowri²

Affiliation:

1. Department of Pharmacology & Therapeutics College of Medicine & Medical Sciences Arabian Gulf University Manama Kingdom of Bahrain

2. Department of Dental Training Ministry of Health Manama Kingdom of Bahrain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13334

Reference43 articles.

1. The effect of CYP2C9*2, CYP2C9*3, and VKORC1‐1639 G>A polymorphism in patients under warfarin therapy in city of Kermanshah;Hosseinkhani Z;Res Pharm Sci,2018

2. Warfarin.Package inserts. United States Food and Drug Administration.https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/009218s107lbl.pdf. Accessed September 7 2020.

3. Impact of the CYP4F2 gene polymorphisms on the warfarin maintenance dose: A systematic review and meta-analysis

4. Impact of the CYP4F2 gene polymorphisms on the warfarin maintenance dose: A systematic review and meta-analysis

5. Impact of gene polymorphism on the initiation and maintenance phases of warfarin therapy in Chinese patients undergoing heart valve replacement;Liu J;Am J Transl Res,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-04-30

2. Estimation of the benefit from pre‐emptive genotyping based on the nationwide cohort data in South Korea;Clinical and Translational Science;2024-03

3. Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice;BMC Cardiovascular Disorders;2023-05-31

4. Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations;Pharmacogenomics;2023-04

5. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection;Open Life Sciences;2023-01-01